In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...

The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...

Anam Waheed, MD, FACC, spoke with Ron Blankstein, MD, FACC, about leadership, education and advocacy in the cardiovascular imaging field. Blankstein is a professor of Medicine and Radiology at Harvard ...

IVL TAVR was associated with a higher rate of the primary composite outcome driven by a higher rate of vascular complications, surgical vascular intervention, and major bleeding compared to non-IVL ...

Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...

In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...

Patients younger than 65 years who received balloon-expandable valve TAVR for severe aortic stenosis during the low-surgical risk era were more likely to have comorbidities and exhibited higher rates ...

Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in ...

Statins promote coronary plaque stabilization though collagen pathways independently of low-density lipoprotein level reduction among patients living with HIV. Artificial intelligence–driven ...

A small proportion of patients with STEMI treated via primary PCI experienced late ventricular tachycardia (VT) or ventricular fibrillation (VF), occurring one or more days following the procedure, ...

In recent years, patients with heart failure (HF) are benefiting more and more from a rapidly evolving management landscape, driven by advances in understanding its pathophysiology along with ...